Bajaj Healthcare · NSE: BAJAJHCARE · BSE: 539872
Q2 FY25 results · Jul–Sep 2024
Bajaj Healthcare reported revenue from operations of ₹133.09 crore (up 31.5% from Q2 FY24) and net profit of ₹9.46 crore for Q2 FY25 (Jul–Sep 2024), on a standalone basis.
| Item | Q2 FY25 | Q2 FY24 | YoY | Q1 FY25 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 133.09 | 101.21 | +31.5% | 132.25 | +0.6% |
| Other income | 2.61 | 1.22 | +114.2% | 0.85 | +205.2% |
| Total income | 135.70 | 102.43 | +32.5% | 133.10 | +1.9% |
| Profit before tax | 12.45 | 5.24 | +137.4% | 10.18 | +22.2% |
| Net profit for the period | 9.46 | (3.46) | Turned profit | 7.13 | +32.7% |
| EPS, basic (₹) | 3.36 | (1.25) | not comparable | 2.59 | not comparable |
| Net margin (%) | 7.1 | -3.4 | 5.4 |
Standalone
- Filed with BSE
- 15 Nov 2024, 17:29 IST
- Board meeting
- 14 Nov 2024
- Period
- 01 Jul 2024 to 30 Sep 2024
- Review status
- Unaudited
- Source
- XBRL filing on BSE